Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genome-wide association studies (GWASs) have identified SNPs of the fat mass and obesity (FTO) gene as the most important risk alleles for obesity. However, how the presence of risk alleles affect phenotype is still a matter of intense investigation. In 2014, a study revealed that long-range enhancers from the intronic regions of the FTO gene regulate iroquois-class homeobox protein (IRX)3 expression.
IRX3
is expressed in hypothalamic
pro-opiomelanocortin (POMC)
neurons and changes in its expression levels affect body adiposity by modifying food intake and energy expenditure. These findings have placed
IRX3
as a potential target for the treatment of obesity. Here, we review studies that evaluated the roles of
IRX3
in development, neurogenesis, and body energy homeostasis.
...
PMID:Hypothalamic IRX3: A New Player in the Development of Obesity. 3203 36